Affordable inactivated poliovirus vaccine: strategies and progress.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Infectious Diseases

• Publication date

  2014-11-01

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.1093/infdis/jiu128PMID 25316868
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meeting of the Strategic Advisory Group of Experts on immunization, November 2013 -- conclusions and recommendations.

  2014cited by this paper
• Priming after a fractional dose of inactivated poliovirus vaccine.

  2013cited by this paper
• Poliovirus vaccination options for achieving eradication and securing the endgame.

  2013cited by this paper
• Measles vaccination using a microneedle patch.

  2013cited by this paper
• Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.

  2013cited by this paper
• Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.

  2013cited by this paper
• Meeting of the Strategic Advisory Group of Experts on immunization, April 2012--conclusions and recommendations.

  2012cited by this paper
• Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain.

  2012cited by this paper
• Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines.

  2012cited by this paper
• Emerging human papillomavirus vaccines

  2012cited by this paper
• Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination.

  2012cited by this paper
• [Poliovirus vaccine].

  2012cited by this paper
• Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.

  2011cited by this paper
• Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions.

  2011cited by this paper
• The polio endgame.

  2011cited by this paper
• Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains

  2011cited by this paper
• Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement

  2011cited by this paper
• Dissolving Polymer Microneedle Patches for Influenza Vaccination

  2010cited by this paper
• Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.

  2010cited by this paper
• Polio vaccines and polio immunization in the pre-eradication era: WHO position paper--recommendations.

  2010cited by this paper
• Polio vaccines and polio immunization in the pre-eradication era: WHO position paper.

  2010cited by this paper
• Fractional doses of inactivated poliovirus vaccine in Oman.

  2010cited by this paper
• Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization.

  2010cited by this paper
• Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.

  2010cited by this paper
• Poliovirus vaccine and vaccine-derived polioviruses.

  2010cited by this paper
• [Feasibility study of using Sabin-IPV immunization in post-eradication era in China].

  2010cited by this paper
• CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.

  2009cited by this paper
• Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.

  2009cited by this paper
• New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.

  2008cited by this paper
• 1,25-dihydroxyvitamin d3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice.

  2006cited by this paper
• Development of inactivated poliovirus vaccine derived from Sabin strains.

  2006cited by this paper
• Vaccine-derived polioviruses and the endgame strategy for global polio eradication.

  2005cited by this paper
• Apparent global interruption of wild poliovirus type 2 transmission.

  2001cited by this paper
• Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine.

  1998cited by this paper
• Immune response of infants to inactivated poliovirus vaccine injected intradermally.

  1992cited by this paper
• Immune response to intradermally injected inactivated poliovirus vaccine.

  1991cited by this paper
• LIVE POLIOVIRUS VACCINES

  1960cited by this paper
• Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress.

  1953cited by this paper
• Recent studies on immunization against poliomyelitis.

  1953cited by this paper
• STUDIES in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress.

  1953cited by this paper

• Immunogenicity, Safety and Immune Persistence of Sabin Strain Inactivated Poliovirus Vaccine: A Phase III Clinical Trial.

  2026cites this paper
• Case Report: Infant with vaccine-associated paralytic poliomyelitis unveils global disparities in care for inborn errors of immunity.

  2026cites this paper
• Safety and immunogenicity of a reduced-dose inactivated poliovirus vaccine versus a full-dose inactivated poliovirus vaccine in infants in Bangladesh: a double-blind, non-inferiority, randomised, controlled, phase 3 trial.

  2025cites this paper
• Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines

  2025cites this paper
• Immunogenicity and non-inferiority evaluation of dose-sparing adjuvanted inactivated polio vaccine in Wistar rats.

  2025cites this paper
• Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance

  2024cites this paper
• Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months

  2024cites this paper
• Oral polio vaccine stockpile modeling: insights from recent experience

  2023cites this paper
• Innovation-driven trend shaping COVID-19 vaccine development in China

  2023cites this paper
• Dose-sparing effect of Sabin-derived inactivated polio vaccine produced in Japan by intradermal injection device for rats.

  2023cites this paper
• Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age

  2022cites this paper
• Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats.

  2022cites this paper
• Defining the optimal intranasal administration strategy for inactivated poliovirus vaccine

  2022cites this paper
• Promising opportunities to improve polio vaccines

  2022cites this paper
• Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial

  2022cites this paper
• Cross-neutralization Capacity of Immune Serum from Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization against Multiple Individual Polioviruses

  2021cites this paper
• Immune responses induced by different vaccine platforms against coronavirus disease-19

  2021cites this paper
• Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries

  2021cites this paper
• Fractional-dose IPV in polio eradication.

  2021cites this paper
• Surveillance of adverse events following the introduction of inactivated poliovirus vaccine made from Sabin strains (sIPV) to the Chinese EPI and a comparison with adverse events following inactivated poliovirus vaccine made from wild strains (wIPV) in Jiangsu, China

  2021cites this paper
• Safety and immunogenicity of experimental stand-alone trivalent, inactivated Sabin-strain polio vaccine formulations in healthy infants: A randomized, observer-blind, controlled phase 1/2 trial

  2020cites this paper
• Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study

  2020influential citation
• Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults

  2020cites this paper
• A novel gamma radiation-inactivated sabin-based polio vaccine

  2020cites this paper
• Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China

  2019cites this paper
• Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial.

  2019cites this paper
• Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis.

  2019cites this paper
• Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies.

  2019cites this paper
• Projection of costs of polio eradication compared to permanent control.

  2019cites this paper
• Universal ELISA for quantification of D-antigen in inactivated poliovirus vaccines.

  2019cites this paper
• Protocol for a systematic review and meta-analysis of fractional dose compared with standard dose inactivated polio vaccination in children

  2019cites this paper
• The effect of formulation on spray dried Sabin inactivated polio vaccine

  2018cites this paper
• Drying Made Easy : Spray drying a promising technology for the production of stable vaccine and therapeutic protein formulations

  2018cites this paper
• Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis

  2018cites this paper
• Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV)

  2018cites this paper
• 48 – Poliovirus Vaccine–Inactivated

  2018cites this paper
• Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?

  2017cites this paper
• Immunogenicity of antigen-conjugated biodegradable polydiacetylene liposomes administered mucosally.

  2017cites this paper
• Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use

  2017cites this paper
• Exploring new packaging and delivery options for the immunization supply chain.

  2017cites this paper
• Intranasal and sublingual delivery of inactivated polio vaccine.

  2017cites this paper
• Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial

  2017cites this paper
• Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV)

  2017cites this paper
• Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization

  2017cites this paper
• Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial

  2017cites this paper
• Repeated fractional intradermal dosing of an inactivated polio vaccine by a single hollow microneedle leads to superior immune responses.

  2016cites this paper
• A Brief History of Vaccines Against Polio.

  2016cites this paper
• Adjuvants in micro- to nanoscale: current state and future direction.

  2016cites this paper
• Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats

  2016cites this paper
• Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame

  2016cites this paper
• Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses

  2016cites this paper
• Alternative administration routes and delivery technologies for polio vaccines

  2016cites this paper
• Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy

  2016cites this paper
• Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles

  2016cites this paper
• Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human Diseases.

  2016cites this paper
• The potential benefits of a new poliovirus vaccine for long-term poliovirus risk management.

  2016cites this paper
• Development of novel inactivated poliovirus vaccines: Breaking away from convention

  2015cites this paper
• Disease Eradication by Vaccination

  2015cites this paper
• Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.

  2015cites this paper
• Progress towards development of tb vaccines ( Indicator SO 6 . 1 )

  year unknowncites this paper